Skip to main content
Top
Published in: Critical Care 6/2003

Open Access 01-12-2003 | Research

Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure

Authors: Claude Level, Philippe Chauveau, Olivier Guisset, Marie Cécile Cazin, Catherine Lasseur, Claude Gabinsky, Stéphane Winnock, Danièle Montaudon, Régis Bedry, Caroline Nouts, Odile Pillet, Georges Gbikpi Benissan, Jean Claude Favarel-Guarrigues, Yves Castaing

Published in: Critical Care | Issue 6/2003

Login to get access

Abstract

Objectives

To measure the mass transfer and clearance of procalcitonin (PCT) in patients with septic shock during continuous venovenous hemofiltration (CVVH), and to assess the mechanisms of elimination of PCT.

Setting

The medical department of intensive care.

Design

A prospective, observational study.

Patients

Thirteen critically ill patients with septic shock and oliguric acute renal failure requiring continuous venovenous postdilution hemofiltration with a high-flux membrane (AN69 or polyamide) and a 'conventional' substitution volume (< 2.5 l/hour).

Measurements and main results

PCT was measured with the Lumitest PCT Brahms® in the prefilter and postfilter plasma, in the ultrafiltrate at the beginning of CVVH (T0) and 15 min (T15'), 60 min (T60') and 6 hours (T6h) after setup of CVVH, and in the prefilter every 24 hours during 4 days. Mass transfer was determined and the clearance and the sieving coefficient were calculated according to the mass conservation principle. Plasma and ultrafiltrate clearances, respectively, at T15', T60' and T6h were 37 ± 8.6 ml/min (not significant) and 1.8 ± 1.7 ml/min (P < 0.01), 34.7 ± 4.1 ml/min (not significant) and 2.3 ± 1.8 ml/min (P < 0.01), and 31.5 ± 7 ml/min (not significant) and 5 ± 2.3 ml/min (P < 0.01). The sieving coefficient significantly increased from 0.07 at T15' to 0.19 at T6h, with no difference according to the nature of the membrane. PCT plasma levels were not significantly modified during the course of CCVH.

Conclusions

We conclude that PCT is removed from the plasma of patients with septic shock during CCVH. Most of the mass is eliminated by convective flow, but adsorption also contributes to elimination during the first hours of CVVH. The effect of PCT removal with a conventional CVVH substitution fluid rate (<2.5 l/hour) on PCT plasma concentration seems to be limited, and PCT remains a useful diagnostic marker in these septic patients. The impact of high-volume hemofiltration on the PCT clearance, the mass transfer and the plasma concentration should be evaluated in further studies.
Literature
1.
go back to reference Utgarte H, Silva E, Mercan D, De Mendonca A, Vincent JL: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27: 498-504. 10.1097/00003246-199903000-00024CrossRef Utgarte H, Silva E, Mercan D, De Mendonca A, Vincent JL: Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 1999, 27: 498-504. 10.1097/00003246-199903000-00024CrossRef
2.
go back to reference Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341: 515-518. 10.1016/0140-6736(93)90277-NCrossRefPubMed Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C: High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 1993, 341: 515-518. 10.1016/0140-6736(93)90277-NCrossRefPubMed
3.
go back to reference Meisner M, Tschaikowsky K, Palmaers T, Schmidt J: Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999, 3: 45-50. 10.1186/cc306PubMedCentralCrossRefPubMed Meisner M, Tschaikowsky K, Palmaers T, Schmidt J: Comparison of procalcitonin (PCT) and C-reactive protein (CRP) plasma concentrations at different SOFA scores during the course of sepsis and MODS. Crit Care 1999, 3: 45-50. 10.1186/cc306PubMedCentralCrossRefPubMed
4.
go back to reference Brunkhorst FM, Heinz U, Forycki ZF: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998, 24: 888-892. 10.1007/s001340050683CrossRefPubMed Brunkhorst FM, Heinz U, Forycki ZF: Kinetics of procalcitonin in iatrogenic sepsis. Intensive Care Med 1998, 24: 888-892. 10.1007/s001340050683CrossRefPubMed
5.
go back to reference Hoffmann G, Czechowski M, Schoesser M, Schobersberger W: Procalcitonin amplifies inductible nitric oxyde synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002, 30: 2091-2095. 10.1097/00003246-200209000-00023CrossRefPubMed Hoffmann G, Czechowski M, Schoesser M, Schobersberger W: Procalcitonin amplifies inductible nitric oxyde synthase gene expression and nitric oxide production in vascular smooth muscle cells. Crit Care Med 2002, 30: 2091-2095. 10.1097/00003246-200209000-00023CrossRefPubMed
6.
go back to reference Level C, Chauveau P, Delmas Y, Lasseur C, Pelle G, Peuchant E, Montaudon D, Combe C: Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001, 16: 980-986. 10.1093/ndt/16.5.980CrossRefPubMed Level C, Chauveau P, Delmas Y, Lasseur C, Pelle G, Peuchant E, Montaudon D, Combe C: Procalcitonin: a new marker of inflammation in haemodialysis patients? Nephrol Dial Transplant 2001, 16: 980-986. 10.1093/ndt/16.5.980CrossRefPubMed
7.
go back to reference Meisner M, Schmidt J, Hüntter H, Tschaikowsky K: The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000, 26: S212-S216. 10.1007/s001340051146CrossRefPubMed Meisner M, Schmidt J, Hüntter H, Tschaikowsky K: The natural elimination rate of procalcitonin in patients with normal and impaired renal function. Intensive Care Med 2000, 26: S212-S216. 10.1007/s001340051146CrossRefPubMed
8.
go back to reference Liano F, Junco E, Pascual J, Madero R, Verde E: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int 1998, 53: 16-24. Liano F, Junco E, Pascual J, Madero R, Verde E: The spectrum of acute renal failure in the intensive care unit compared with that seen in other settings. Kidney Int 1998, 53: 16-24.
9.
go back to reference Yhijs A, Thijs L: Pathogenis of renal failure in sepsis. Kidney Int 1998, 53: 34-37. Yhijs A, Thijs L: Pathogenis of renal failure in sepsis. Kidney Int 1998, 53: 34-37.
10.
go back to reference Honoré PM, Jamez J, Wauthier M, Pirenne B, Pelgrim J, Dugernier T: Removal of mediators by hemofiltration in septic shock: where do we stand? Réanim Urgences 2000, 9: 289-297.CrossRef Honoré PM, Jamez J, Wauthier M, Pirenne B, Pelgrim J, Dugernier T: Removal of mediators by hemofiltration in septic shock: where do we stand? Réanim Urgences 2000, 9: 289-297.CrossRef
11.
go back to reference Nylen ES, Whang KT, Snider RH, Steinwald P, White J, Becker K: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998, 26: 1001-1006. 10.1097/00003246-199806000-00015CrossRefPubMed Nylen ES, Whang KT, Snider RH, Steinwald P, White J, Becker K: Mortality is increased by procalcitonin and decreased by an antiserum reactive to procalcitonin in experimental sepsis. Crit Care Med 1998, 26: 1001-1006. 10.1097/00003246-199806000-00015CrossRefPubMed
12.
go back to reference Bone RC, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, Schein R, Sibbald WJ, for the ACCP/SCCM Conference Consensus: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101: 1644-1655.CrossRefPubMed Bone RC, Balk R, Cerra F, Dellinger R, Fein A, Knaus W, Schein R, Sibbald WJ, for the ACCP/SCCM Conference Consensus: Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Chest 1992, 101: 1644-1655.CrossRefPubMed
13.
go back to reference Brunet S, Leblanc M, Geadah D, Parent D, Couteau S, Cardinal J: Diffusive and convective solute clearances during continuous replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999, 34: 486-492.CrossRefPubMed Brunet S, Leblanc M, Geadah D, Parent D, Couteau S, Cardinal J: Diffusive and convective solute clearances during continuous replacement therapy at various dialysate and ultrafiltration flow rates. Am J Kidney Dis 1999, 34: 486-492.CrossRefPubMed
14.
go back to reference Meisner M, Hüttmann E, Lohs T, Kasakov L, Reinhart K: Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 2001, 15: 171-175.CrossRefPubMed Meisner M, Hüttmann E, Lohs T, Kasakov L, Reinhart K: Plasma concentrations and clearance of procalcitonin during continuous veno-venous hemofiltration in septic patients. Shock 2001, 15: 171-175.CrossRefPubMed
15.
go back to reference Dahaba A, Elawady G, Rehak P, List W: Procalcitonin and proinflammatory cytokine clearance during continuous venove-nous haemofiltration in septic patients. Anaesth Intensive Care 2002, 30: 269-274.PubMed Dahaba A, Elawady G, Rehak P, List W: Procalcitonin and proinflammatory cytokine clearance during continuous venove-nous haemofiltration in septic patients. Anaesth Intensive Care 2002, 30: 269-274.PubMed
16.
go back to reference Matson J, Lee P: Evolving concepts of therapy for sepsis and septic shock and the use of hyperpermeable membranes. Curr Opin Crit Care 2000, 6: 431-436. 10.1097/00075198-200012000-00011CrossRef Matson J, Lee P: Evolving concepts of therapy for sepsis and septic shock and the use of hyperpermeable membranes. Curr Opin Crit Care 2000, 6: 431-436. 10.1097/00075198-200012000-00011CrossRef
17.
go back to reference Subramanian S, Venkataraman R, Kellum JA: Influence of dialysis membrane on outcomes in acute renal failure: a meta-analysis. Kidney Int 2002, 62: 1819-1823. 10.1046/j.1523-1755.2002.00608.xCrossRefPubMed Subramanian S, Venkataraman R, Kellum JA: Influence of dialysis membrane on outcomes in acute renal failure: a meta-analysis. Kidney Int 2002, 62: 1819-1823. 10.1046/j.1523-1755.2002.00608.xCrossRefPubMed
18.
go back to reference Subramanian S, Kellum JA: Convection or diffusion in continuous renal replacement therapy for sepsis. Curr Opin Crit Care 2000, 6: 426-430. 10.1097/00075198-200012000-00010CrossRef Subramanian S, Kellum JA: Convection or diffusion in continuous renal replacement therapy for sepsis. Curr Opin Crit Care 2000, 6: 426-430. 10.1097/00075198-200012000-00010CrossRef
19.
go back to reference Valette P, Thomas M, Déjardin P: Adsorption of low molecular weight proteins to hemodialysis membranes: experimental results and simulations. Biomaterials 1999, 20: 1621-1634. 10.1016/S0142-9612(99)00070-8CrossRefPubMed Valette P, Thomas M, Déjardin P: Adsorption of low molecular weight proteins to hemodialysis membranes: experimental results and simulations. Biomaterials 1999, 20: 1621-1634. 10.1016/S0142-9612(99)00070-8CrossRefPubMed
20.
go back to reference European Best Practice Guidelines Expert Group on Haemodialysis: Section III. Biocompatibility. Nephrol Dial Transplant 2002, 17: 32-44. European Best Practice Guidelines Expert Group on Haemodialysis: Section III. Biocompatibility. Nephrol Dial Transplant 2002, 17: 32-44.
21.
go back to reference Ronco C, Brendolan A, Lupi A, Metry G, Levin N: Effects of a reduced inner diameter of hollow fibers in haemodialyzers. Kidney Int 2000, 58: 809-817. 10.1046/j.1523-1755.2000.00230.xCrossRefPubMed Ronco C, Brendolan A, Lupi A, Metry G, Levin N: Effects of a reduced inner diameter of hollow fibers in haemodialyzers. Kidney Int 2000, 58: 809-817. 10.1046/j.1523-1755.2000.00230.xCrossRefPubMed
22.
go back to reference Tetta C, Bellomo R, Brendolan A, Piccini P, Digito A, Dan M, Irone M, Lonneman G, Moscato D, Buades J, Lagreca G, Ronco C: Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill. Kidney Int 1999, 56: S15-S19.CrossRef Tetta C, Bellomo R, Brendolan A, Piccini P, Digito A, Dan M, Irone M, Lonneman G, Moscato D, Buades J, Lagreca G, Ronco C: Use of adsorptive mechanisms in continuous renal replacement therapies in the critically ill. Kidney Int 1999, 56: S15-S19.CrossRef
23.
go back to reference De Vriese ANS, Colardyn F, Philippé J, Vanholder R, Desutter J, Lameire N: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10: 846-853.PubMed De Vriese ANS, Colardyn F, Philippé J, Vanholder R, Desutter J, Lameire N: Cytokine removal during continuous hemofiltration in septic patients. J Am Soc Nephrol 1999, 10: 846-853.PubMed
24.
go back to reference Vincent JL, Tielemans C: Continuous hemofiltration in severe sepsis: is it beneficial? J Crit Care 1995, 10: 27-32. 10.1016/0883-9441(95)90028-4CrossRefPubMed Vincent JL, Tielemans C: Continuous hemofiltration in severe sepsis: is it beneficial? J Crit Care 1995, 10: 27-32. 10.1016/0883-9441(95)90028-4CrossRefPubMed
25.
go back to reference Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccini P, Lagreca P: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356: 26-30. 10.1016/S0140-6736(00)02430-2CrossRefPubMed Ronco C, Bellomo R, Homel P, Brendolan A, Dan M, Piccini P, Lagreca P: Effects of different doses in continuous veno-venous haemofiltration on outcomes of acute renal failure: a prospective randomised trial. Lancet 2000, 356: 26-30. 10.1016/S0140-6736(00)02430-2CrossRefPubMed
26.
go back to reference Brause M, Neuman A, Schumacher T, Grabense B, Heering P: Effect of filtration volume of continuous veno-venous hemofiltration in the treatment of patients with acute renal failure in intensive care units. Crit Care Med 2003, 31: 841-846. 10.1097/01.CCM.0000054866.45509.D0CrossRefPubMed Brause M, Neuman A, Schumacher T, Grabense B, Heering P: Effect of filtration volume of continuous veno-venous hemofiltration in the treatment of patients with acute renal failure in intensive care units. Crit Care Med 2003, 31: 841-846. 10.1097/01.CCM.0000054866.45509.D0CrossRefPubMed
27.
go back to reference Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hannique G, Matson JF: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28: 3581-3587.CrossRefPubMed Honore PM, Jamez J, Wauthier M, Lee PA, Dugernier T, Pirenne B, Hannique G, Matson JF: Prospective evaluation of short-term, high-volume isovolemic hemofiltration on the hemodynamic course and outcome in patients with intractable circulatory failure resulting from septic shock. Crit Care Med 2000, 28: 3581-3587.CrossRefPubMed
Metadata
Title
Mass transfer, clearance and plasma concentration of procalcitonin during continuous venovenous hemofiltration in patients with septic shock and acute oliguric renal failure
Authors
Claude Level
Philippe Chauveau
Olivier Guisset
Marie Cécile Cazin
Catherine Lasseur
Claude Gabinsky
Stéphane Winnock
Danièle Montaudon
Régis Bedry
Caroline Nouts
Odile Pillet
Georges Gbikpi Benissan
Jean Claude Favarel-Guarrigues
Yves Castaing
Publication date
01-12-2003
Publisher
BioMed Central
Published in
Critical Care / Issue 6/2003
Electronic ISSN: 1364-8535
DOI
https://doi.org/10.1186/cc2372

Other articles of this Issue 6/2003

Critical Care 6/2003 Go to the issue

Web report

SARS Resources